Literature DB >> 24284624

Cancer: Discrepancies in drug sensitivity.

John N Weinstein1, Philip L Lorenzi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24284624     DOI: 10.1038/nature12839

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Development of human tumor cell line panels for use in disease-oriented drug screening.

Authors:  R H Shoemaker; A Monks; M C Alley; D A Scudiero; D L Fine; T L McLemore; B J Abbott; K D Paull; J G Mayo; M R Boyd
Journal:  Prog Clin Biol Res       Date:  1988

2.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

3.  An information-intensive approach to the molecular pharmacology of cancer.

Authors:  J N Weinstein; T G Myers; P M O'Connor; S H Friend; A J Fornace; K W Kohn; T Fojo; S E Bates; L V Rubinstein; N L Anderson; J K Buolamwini; W W van Osdol; A P Monks; D A Scudiero; E A Sausville; D W Zaharevitz; B Bunow; V N Viswanadhan; G S Johnson; R E Wittes; K D Paull
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

4.  Inconsistency in large pharmacogenomic studies.

Authors:  Benjamin Haibe-Kains; Nehme El-Hachem; Nicolai Juul Birkbak; Andrew C Jin; Andrew H Beck; Hugo J W L Aerts; John Quackenbush
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

5.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

6.  Systematic identification of genomic markers of drug sensitivity in cancer cells.

Authors:  Mathew J Garnett; Elena J Edelman; Sonja J Heidorn; Chris D Greenman; Anahita Dastur; King Wai Lau; Patricia Greninger; I Richard Thompson; Xi Luo; Jorge Soares; Qingsong Liu; Francesco Iorio; Didier Surdez; Li Chen; Randy J Milano; Graham R Bignell; Ah T Tam; Helen Davies; Jesse A Stevenson; Syd Barthorpe; Stephen R Lutz; Fiona Kogera; Karl Lawrence; Anne McLaren-Douglas; Xeni Mitropoulos; Tatiana Mironenko; Helen Thi; Laura Richardson; Wenjun Zhou; Frances Jewitt; Tinghu Zhang; Patrick O'Brien; Jessica L Boisvert; Stacey Price; Wooyoung Hur; Wanjuan Yang; Xianming Deng; Adam Butler; Hwan Geun Choi; Jae Won Chang; Jose Baselga; Ivan Stamenkovic; Jeffrey A Engelman; Sreenath V Sharma; Olivier Delattre; Julio Saez-Rodriguez; Nathanael S Gray; Jeffrey Settleman; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Sridhar Ramaswamy; Ultan McDermott; Cyril H Benes
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

  6 in total
  18 in total

1.  Consistency in drug response profiling.

Authors:  John Patrick Mpindi; Bhagwan Yadav; Päivi Östling; Prson Gautam; Disha Malani; Astrid Murumägi; Akira Hirasawa; Sara Kangaspeska; Krister Wennerberg; Olli Kallioniemi; Tero Aittokallio
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

2.  Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance.

Authors:  J Jack; G W Small; C C Brown; T M Havener; H L McLeod; A A Motsinger-Reif; K L Richards
Journal:  Pharmacogenomics J       Date:  2017-12-05       Impact factor: 3.550

3.  Evaluating the consistency of large-scale pharmacogenomic studies.

Authors:  Raziur Rahman; Saugato Rahman Dhruba; Kevin Matlock; Carlos De-Niz; Souparno Ghosh; Ranadip Pal
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

4.  An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.

Authors:  Chao Cheng; Yanding Zhao; Evelien Schaafsma; Yi-Lan Weng; Christopher Amos
Journal:  Int J Cancer       Date:  2020-06-04       Impact factor: 7.396

Review 5.  In vitro human cell line models to predict clinical response to anticancer drugs.

Authors:  Nifang Niu; Liewei Wang
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

Review 6.  Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.

Authors:  Cory M Johannessen; Paul A Clemons; Bridget K Wagner
Journal:  Trends Genet       Date:  2014-12-12       Impact factor: 11.639

Review 7.  Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.

Authors:  William C Reinhold; Sudhir Varma; Vinodh N Rajapakse; Augustin Luna; Fabricio Garmus Sousa; Kurt W Kohn; Yves G Pommier
Journal:  Hum Genet       Date:  2014-09-12       Impact factor: 4.132

Review 8.  Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics.

Authors:  Andrew Goodspeed; Laura M Heiser; Joe W Gray; James C Costello
Journal:  Mol Cancer Res       Date:  2015-08-06       Impact factor: 5.852

9.  Paired image- and FACS-based toxicity assays for high content screening of spheroid-type tumor cell cultures.

Authors:  Kari Trumpi; David A Egan; Thomas T Vellinga; Inne H M Borel Rinkes; Onno Kranenburg
Journal:  FEBS Open Bio       Date:  2015-01-28       Impact factor: 2.693

Review 10.  Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy.

Authors:  José E Belizário; Beatriz A Sangiuliano; Marcela Perez-Sosa; Jennifer M Neyra; Dayson F Moreira
Journal:  Front Pharmacol       Date:  2016-09-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.